Showing results (211-220 of 1,399) with videos related to

Sort By:
Pageof 140
Pharmacology Research & Perspectives|March 20, 2023
A pharmacokinetic drug-drug interaction study between rosuvastatin and emvododstat, a potent anti-SARS-CoV-2 (COVID-19) DHODH (dihydroorotate dehydrogenase) inhibitorTerri L Morton, Oscar L Laskin, Diksha Kaushik, et al.
Pharmacology Research & Perspectives|February 22, 2023
Defined daily doses in pediatric dosing- a theoretical exampleElin Dahlén, Jenny Marianne Kindblom, Elin Eyfells Kimland
Pharmacology Research & Perspectives|February 22, 2023
Mechanistic in vitro studies indicate that the clinical drug-drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3Robert Elsby, Hannah Coghlan, Jacob Edgerton, et al.
Pharmacology Research & Perspectives|May 6, 2021
A phase I, single and continuous dose administration study on the safety, tolerability, and pharmacokinetics of neorudin, a novel recombinant anticoagulant protein, in healthy subjectsYubin Liu, Meixia Wang, Xiaona Dong, et al.
Pharmacology Research & Perspectives|May 2, 2021
Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals' preferencesMarloes Dankers, Marjorie H J M G Nelissen-Vrancken, Bertien H Hart, et al.
Pharmacology Research & Perspectives|September 3, 2021
Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: New perspectives from a single-center observational studyAndrea Pasta, Paolo Borro, Anna Laura Cremonini, et al.
Pharmacology Research & Perspectives|September 3, 2021
Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantificationKata W Pedersen, Jakob Hansen, Jørgen B Hasselstrøm, et al.
Pharmacology Research & Perspectives|August 9, 2021
A Phase 1 first-in-human study of the safety, tolerability, and pharmacokinetics of the ROBO2 fusion protein PF-06730512 in healthy participantsChay Ngee Lim, Constantino Kantaridis, Isabelle Huyghe, et al.
Pharmacology Research & Perspectives|August 2, 2021
Polypharmacy and mortality association by chronic kidney disease status: The REasons for Geographic And Racial Differences in Stroke StudyWinn Cashion, William McClellan, Suzanne Judd, et al.
Pharmacology Research & Perspectives|January 28, 2023
Fatty acids negatively regulate platelet function through formation of noncanonical 15-lipoxygenase-derived eicosanoidsAdriana Yamaguchi, Christopher van Hoorebeke, Benjamin E Tourdot, et al.
Pageof 140